Cerenome unit CNSide Diagnostics sets Sept. 30 CNSide business update call

• CNSide Diagnostics, a wholly owned unit of Cerenome, will host a CNSide business update call on Sept. 30, 2026.
• Update centers on commercial execution for the CNSide cerebrospinal fluid diagnostic platform launched in early 2026.
• Discussion to address third-party billing, market access, commercial team expansion, broadening of the diagnostic testing portfolio.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cerenome Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609250730PRIMZONEFULLFEED9833845) on September 25, 2026, and is solely responsible for the information contained therein.